Leila Alland, Chief Medical Officer at PMV Pharmaceuticals, Inc. (PMVP), sold 8,718 shares at $35.06 ($296K) on 2021-08-09, disclosed to the SEC on 2021-08-10.
Open-market sale of $296k PMVP by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.66 | 2,049 | $67K | 22.6% |
| 2 | $32.66 | 2,049 | $67K | 22.6% |
| 3 | $35.06 | 2,198 | $77K | 26.0% |
| 4 | $35.06 | 2,198 | $77K | 26.0% |
| 5 | $36.69 | 224 | $8K | 2.8% |
| Total | $33.97 avg | 8,718 |
| $296K |
| 100% |
| Filing → |
| ABEO | BUY | 2024-05-20 | $52K | — | Filing → |
| ABEO | SELL | 2023-09-29 | $28K | — | Filing → |
| PMVP | SELL | 2023-09-18 | $42K | — | Filing → |